Brief: Passage Bio Receives FDA Clearance Of Ind Application For Pbml04 For Treatment Of Metachromatic Leukodystrophy

Passage Bio

08/06/2022 13:27

June 8 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO RECEIVES FDA CLEARANCE OF IND APPLICATION FOR
PBML04
FOR TREATMENT OF METACHROMATIC LEUKODYSTROPHY

Source text for Eikon:  ID:nGNX1DF8Vh 
Further company coverage:  PASG.O 

 ((reuters.briefs@thomsonreuters.com;))